Toggle light / dark theme

A GROUNDBREAKING cancer vaccine could stop tumours growing in patients with advanced disease, researchers say.

Designed to prime the body to recognise and fight cancer cells, the jab could stimulate the immune system to help treat the disease more effectively, early trial results show.

Researchers described the results as “an important first step” in developing a new treatment for people with advanced cancers.

The first statistically significant results are in: not only can Large Language Model (LLM) AIs generate new expert-level scientific research ideas, but their ideas are more original and exciting than the best of ours – as judged by human experts.

Recent breakthroughs in large language models (LLMs) have excited researchers about the potential to revolutionize scientific discovery, with models like ChatGPT and Anthropic’s Claude showing an ability to autonomously generate and validate new research ideas.

This, of course, was one of the many things most people assumed AIs could never take over from humans; the ability to generate new knowledge and make new scientific discoveries, as opposed to stitching together existing knowledge from their training data.

ChatGPT maker OpenAI is rumored to be imminently releasing a brand-new AI model, internally dubbed “Strawberry,” that has a “human-like” ability to reason.

As Bloomberg reports, a person familiar with the project says it could be released as soon as this week.

We’ve seen rumors surrounding an OpenAI model capable of reasoning swirl for many months now. In November, Reuters and The Information reported that the company was working on a shadowy project called Q — pronounced Q-Star — which was alleged to represent a breakthrough in OpenAI’s efforts to realize artificial general intelligence, the theoretical point at which an AI could outperform a human.

Researchers at Rolls-Royce University Technology Centre (UTC) in Manufacturing and On-Wing Technology at the University of Nottingham have developed ultra-thin soft robots, designed for exploring narrow spaces in challenging built environments. The research is published in the journal Nature Communications.

These advanced robots, featuring multimodal locomotion capabilities, are set to transform the way industries, such as , bridges and aero engines, conduct inspections and maintenance.

The innovative robots, known as Thin Soft Robots (TS-Robots), boast a thin thickness of just 1.7mm, enabling them to access and navigate in confined spaces, such as millimeter-wide gaps beneath doors or within complex machinery.

A bowel cancer trial has seen all participants emerge cancer-free, indicating “extremely positive” development for treatment.

Bowel cancer is the fourth most common cancer in the UK, with cases in under-50s seeing a rise in recent years. Thanks to campaigners like Dame Deborah James, more people are having bowel cancer checks – important, as chances of survival are greater when caught early.

When caught in the early stages, 90 per cent of those treated with stage one bowel cancer will survive for five or more years. The figure falls to 65 per cent at stage three, and to 10 per cent at stage four.

Cancer treatment has reached a new milestone with the development of an innovative method to destroy cancer cells using molecular jackhammers, offering hope for more targeted and efficient therapies.

This cutting-edge approach utilizes advanced molecular science to disrupt cancer cells in a way that could minimize harm to healthy tissue.

A collaborative team of scientists has found that stimulating aminocyanine molecules with near-infrared light causes them to vibrate in sync, producing enough force to effectively rupture the membranes of cancer cells without invasive procedures.